Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00196_DB01124_nanopub.RALxfuZDcEk-Jhdx2Hqi-pQ4s4a3Q0pZhTi5f0XnAmq1g#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00196_DB01124 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB01124 label "DDI between Fluconazole and Tolbutamide - Fluconazole, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Tolbutamide, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in Fluconazole therapeutic and adverse effects if Delavirdine is initiated, discontinued or dose changed. [drugbank_resource:DB00196_DB01124]" assertion.
- drugbank_resource:DB00196_DB01124 identifier "drugbank_resource:DB00196_DB01124" assertion.
- drugbank_resource:DB00196_DB01124 title "DDI between Fluconazole and Tolbutamide - Fluconazole, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Tolbutamide, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in Fluconazole therapeutic and adverse effects if Delavirdine is initiated, discontinued or dose changed." assertion.
- drugbank:DB01124 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB01124 assertion.
- drugbank:DB00196 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB01124 assertion.